Top Cars Expected to Hit the Road in August 2025
Volvo XC60 Facelift
Volvo – Known to be one of the most stylish cars, is first on the list. The Volvo XC60 Facelift which was globally launched in early 2025, was launched in India on the 1st of August. The Volvo XC60 Facelift brings subtle styling updates like a diagonal-slat grille, smoked LED taillights, new alloys and fresh colours. At the same time, there are interior upgrades like an 11.2″ Snapdragon-powered touchscreen, premium materials, massaging seats, panoramic sunroof and Level-2 ADAS. It is priced at an ex-showroom Rs 71.90 lakh in India.
Features and Specs
Engine: 2.0-litre turbocharged petrol mild-hybrid (B5)
Power: 250 hp
Torque: 350 Nm
Transmission: 8-speed automatic with all-wheel drive (AWD)
Mercedes-AMG CLE 53 Coupe
For those who are waiting for a high-performance coupe in India, the Mercedes-AMG CLE 53 Coupe is making its debut in India. This performance machine looks extremely stylish with a vertical-slat Panamericana grille, sleek LED DRLs, wide flared fenders, sculpted hood with vents, optional 20″ AMG alloys, quad exhausts and a sporty diffuser. The expected ex-showroom price is approximately Rs 2.00 crore.
Features and Specs
Engine: 3.0L twin-turbocharged inline-six mild-hybrid
Power: 443 bhp
Torque: 560 Nm
Transmission: 9-speed AMG Speedshift automatic
VinFast VF 7
VinFast is ready to make a debut in India by mid-August 2025. This Vietnamese brand is making its way to the Indian market with two of its electric vehicles – The VinFast VF 7 and VinFast VF 6. VF 7 is a compact 5-seater car. It comes in two variants – The Eco Variant and the Plus Variant. The approximate price of this car is Rs 30–35 lakh.
Features and Specs
Battery Capacity: 70.8 kWh
Range: Eco – Approx 450 km
Plus – Approx 431 km
Power: Eco FWD variant: Approx 201 bhp (150–204 PS) & 310 Nm torque
Plus AWD variant: Approx 349–354 bhp (260–350 PS) & 500 Nm torque
VinFast VF 6
VinFast has opened pre-bookings for its compact electric SUV VF 6 on July 15, 2025, with public sales expected by the end of August. Locally assembled in Thoothukudi, Tamil Nadu, it's priced around Rs 18–25 lakh.
Features and Specs
Battery Capacity: A single 59.6 kWh lithium-ion battery pack powers both Eco and Plus trims.
Range: Approx 480 km
Power: 201–204 PS
Mahindra Vision Concepts
Mahindra will unveil four concept SUVs under its new "Nu" platform: Vision T (Thar‑family electric), Vision S (Scorpio‑N EV), Vision SXT (utility‑pickup design), and Vision X.
With these launches, August 2025 is shaping up to be an exciting month for car lovers. Whether you're looking for sporty performance, electric mobility, luxury comfort, or want to try a new brand, there's something new for everyone to explore.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
19 minutes ago
- Indian Express
Tata Sons-backed Tata Capital Ltd files for IPO
Tata Sons-backed non-banking financial company (NBFC), Tata Capital Ltd, filed draft papers on Monday for an initial public offering (IPO). Tata Capital's IPO consists of a combination of fresh issuance and an offer for sale (OFS), amounting to approximately 47.58 crore equity shares. The company will be issuing up to 21 crore new shares and the existing shareholders are looking to offload up to 26.58 crore shares. Tata Sons Private Ltd, the promoter of the company, is planning to sell up to 23 crore shares in the IPO, while International Finance Corporation (IFC) has proposed to sell up to 3.58 crore shares. The issue size is estimated at around Rs 17,000 crore, as per Prime Database. The shares will be issued at a face value of Rs 10 per share. The company will use the proceeds from the fresh issue to augment its tier-1 capital base to meet its future capital requirement, including onward lending. Tata Capital is the third largest diversified NBFC in the country. The Reserve Bank of India has classified it as a systemically important NBFC, which requires stricter regulatory adherence. As per the RBI regulations, Tata Capital is required to be listed by the end of September. Tata Capital, the flagship financial services company of the Tata Group, is a subsidiary of Tata Sons Private Limited. It is primarily engaged in the lending business which comprises retail finance, SME finance and corporate finance. Tata Capital's consolidated book size increased to Rs 2,21,950.37 crore as at March 31, 2025 from Rs 1,57,760.55 crore as at March 31, 2024. During FY25, it recorded consolidated total income of Rs 28,369.87 crore as against Rs 18,198.38 crore in FY24, an increase of about 55.89 per cent. On a standalone basis, Tata Capital's recorded gross income of Rs 21,940.08 crore in FY2024-25, compared to Rs 13,309.11 crore in FY24. Profit after tax during the year was Rs 2,594.28 crore as against Rs 2,492.45 crore.
The Hindu
19 minutes ago
- The Hindu
Tamil Nadu signs MoUs worth ₹32,554 crore at investors conclave
Chief Minister M.K. Stalin asserted here on Monday that Tamil Nadu would keep rising under the Dravidian-model government. He was addressing the gathering at the TN Rising Investors Conclave. The Chief Minister inaugurated the commercial production under four projects located in Tirunelveli, Thoothukudi, and Kancheepuram, at cost of ₹1,230 crore. These projects are expected to create employment opportunities for 3,100 people in these regions. In addition, Memoranda of Understanding (MoUs) were signed in the presence of the Chief Minister for 41 projects across Tamil Nadu, with a total investment of ₹32,554 crore. These projects are expected to create over 49,000 jobs across the State. Of the 41 projects, 19 fall under the micro, small, and medium enterprise (MSME) sector, with a combined investment of ₹265.15 crore. Speaking at the event, Mr. Stalin said, 'The dream that Kalaignar Karunanidhi had for southern Tamil Nadu is now becoming a reality.' Recalling his speech at VinFast manufacturing unit's inaugural event, he added, 'Today is a golden day in the growth of southern districts.' Noting that this is the second time an investors' conclave is being held in Thoothukudi, Mr. Stalin highlighted the city's potential. 'We are committed to developing Thoothukudi, a city with a port, rich natural resources, and skilled workforce into an industrially advanced district,' he said. Mr. Stalin pointed out that special incentives were being provided for the industries setting up operations in the southern industrial parks, which were already equipped with ready-to-use infrastructure. Projects such as the desalination plant in Thoothukudi, Tidel park in Madurai, and PM Mithra Park in Virudgunagar are being set up in the southern districts. A Tidel park in Thoothukudi and TATA power solar and Vikram Solar in Tirunelveli have already been established, he said. Mr. Stalin said southern Tamil Nadu was now witnessing an unprecedented level of development. The current government was functioning with the broad objective of inclusive development and growth for all sectors, all districts and all communities. In line with this, the government has been focusing on emerging sectors such as high-tech semiconductor manufacturing, electric vehicle manufacturing, solar cells production, green hydrogen and information technology services. He announced four projects for Thoothukudi and Tirunelveli districts, including a 256-acre space park and a dedicated ship building industry in Thoothukudi, a common facility centre in Thoothukudi and Tirunelveli at a cost of ₹5.59 crore for moringa export.
&w=3840&q=100)
Business Standard
19 minutes ago
- Business Standard
Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue
Aurobindo Pharma on Monday reported a 10.2% year-on-year (Y-o-Y) drop in consolidated profit after tax (PAT) for the June quarter (Q1 FY26), which stood at Rs 824 crore. The decline was attributed to a drop in sales in its active pharmaceutical ingredients (API) business and the United States (US) market. The Hyderabad-based drugmaker had recorded a net profit of Rs 918 crore in Q1 FY25. The company stated that its API business was affected by pricing pressures and geopolitical tensions, with revenues for the segment falling by 16% Y-o-Y to Rs 916 crore in Q1 FY26. However, the drugmaker recorded a 4% Y-o-Y rise in revenue from operations, reaching Rs 7,868 crore in the June quarter, up from Rs 7,567 crore in Q1 FY25. This increase was primarily driven by a 7.4% Y-o-Y rise in the drugmaker's formulations business revenue, which contributes around 85% of the company's overall revenue. Aurobindo Pharma saw an 18% Y-o-Y revenue growth in European markets, which stood at Rs 2,338 crore, driven by a strong performance across all key markets. Similarly, revenue from growth markets formulations increased by 8.8% Y-o-Y to Rs 772 crore in the June quarter, compared to Rs 709 crore in the same period last year. However, the company's US formulations business, which accounts for 44% of its revenue, saw a marginal 1.9% Y-o-Y dip in sales, from Rs 3,555 crore in Q1 FY25 to Rs 3,488 crore in Q1 FY26. According to the company's regulatory filing, the decline in US revenue was primarily due to a significant reduction in sales of the anti-cancer medication lenalidomide. Commenting on the company's performance, K. Nithyananda Reddy, Vice Chairman and Managing Director of Aurobindo Pharma, said that the company has started FY26 steadily, with its European business maintaining strong growth momentum and the core US business showing resilience despite temporary challenges from destocking and seasonal dynamics. The company announced its results after market hours. On Monday, Aurobindo Pharma's shares rose marginally by 1.04%, ending the day's trade at Rs 1,090.90 apiece on the exchanges.
